ARCHIVED: References: The Management of the National Antiviral Stockpile: Options Report

 

References

i Public Health Agency of Canada (2006).  Canadian Pandemic Influenza Plan for the Health Sector, Planning Assumptions.  Located at:
 http://www.phac-aspc.gc.ca/cpip-pclcpi/

ii Public Health Agency of Canada (2006).  Canadian Pandemic Influenza Plan for the Health Sector, Annex E (revised May 2009).  Located at: http://www.phac-aspc.gc.ca/cpip-pclcpi/

iii Hoffmann-La Roche Ltd.  (rev. April 20 2009). Product Monograph: TAMIFLU.  Located at: http://www.rochecanada.com/portal/eipf/ca/portal/roche/consumer_information

iv Statistics Canada, Demography Division, Demographic Estimates Section, Annual Population Estimates by age and sex for July, 1971 to 2008, 2008 Preliminary PostCensal Estimates

v Public Health Agency of Canada (2006).  Canadian Pandemic Influenza Plan for the Health Sector, Annex E (revised May 2009).  Located at: http://www.phac-aspc.gc.ca/cpip-pclcpi/

vi Hoffmann-La Roche Ltd.  (rev. April 20 2009). Product Monograph: TAMIFLU.  Located at: http://www.rochecanada.com/portal/eipf/ca/portal/roche/consumer_information

vii Public Health Agency of Canada (2006).  Canadian Pandemic Influenza Plan for the Health Sector, Annex E (revised May 2009).  located at: http://www.phac-aspc.gc.ca/cpip-pclcpi/

 

Page details

Date modified: